MXCT
MaxCyte, Inc. · Healthcare
EVP, Global Sales, Marketing Thomas M. Ross sold $50K of MaxCyte, Inc.
Sold$50,084
$5.02Price
9,973Shares
−100%Stake
What MXCT did after the filing
- The stock from Tue, Apr 4 close, $4.95
- −23.0%
- S&P 500, same days
- +1.6%
Measured over 30 trading days, to the May 17 close.
Traded Fri, Mar 31. Filed Tue, Apr 4, 3:00 PM ET, during the session. Returns use the Apr 4 close and the May 17 close. Not investment advice.